1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60CD86CE3CD3D959385256EBC006761A6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/best-practices-driving-growth-through-new-product-planning-strategic-alliances?opendocument
18
19opendocument
2034.204.173.45
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Sales and Marketing New Product Development and Launch Managing Development Process Development Activities

Key Factors in Driving Growth through New Product Planning and Strategic Alliances

DB Image

ID: 4676


Features:

Graphics


Pages/Slides: 5


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Study Overview

To ensure high performance, drive overall growth and allocate resources optimally, pharmaceutical partners need a deeper understanding of how leading companies best structure and manage new product planning and strategic alliance processes. By identifying and adapting the most effective and innovative practices that other top pharmaceutical manufacturers have used, this document will support companies’ efforts to make their new product planning and strategic alliance processes more effective. This five-page document provides a valuable operational compass to guide companies’ efforts to ensure that their processes are effective.

Key Findings

  • Align new product planning and strategic alliance goals with company strategy to drive growth.
    *One partner noted that merely measuring number of deals examined does nothing to encourage strategic alliance personnel to find and develop blockbusters.
  • Recruit and select new product planning and strategic alliance personnel with balanced science and business backgrounds to reduce training needs and ensure quality performance.
    *In one large pharmaceutical partner's department, all upper-level personnel have at least 10 to 20 years of experience.
  • Position new product planning as a central hub for coordinating and managing multi-functional activities to increase internal support and optimized product and portfolio management.
    *The most important aspects of this coordination are rapid, accurate cross-functional communication, providing multiple points of contact to internal and external partners, and centralized management of new product development.

Methodology
The insights and best practices showcased in this report are distilled from lessons learned in interviews with executives and specialists who have extensive experience in designing and managing new product planning and strategic alliance departments at a range of pharmaceutical companies. This document originated from a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Biotech; Health Care


Companies Profiled:
Eli Lilly; Pfizer; Amgen; Janssen

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.